Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Slides:

Advertisements

Similar presentations

Superficial Femoral Artery Recanalization with Self-expanding Nitinol Stents: Long-term Follow-up Results M. Ferreira, L. Lanziotti, M. Monteiro, G.

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Albert C. W. Ting, MS, FRCS, Stephen W. K

Bidirectional endovascular treatment for chronic total occlusive lesions of the femoropopliteal arterial segment using a hand-carried ultrasound device.

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament Keith D. Calligaro, MD, Praveen Balraj, MD, Neil Moudgill, MD,

Bidirectional endovascular treatment for chronic total occlusive lesions of the femoropopliteal arterial segment using a hand-carried ultrasound device.

Stenting of femoropopliteal lesions using interwoven nitinol stents

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score Daniel M. Ihnat,

Thermal laser-assisted balloon angioplasty of the superficial femoral artery: A multicenter review of 602 cases David Rosenthal, MD, Felix A. Pesa, MD,

Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis Bibombe Patrice Mwipatayi, MMed (Surg),

Stephen W. K Cheng, MS, FRCS, FACS, Albert C

Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation Thomas M. Loh,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Prevalence, factors, and clinical impact of self-expanding stent fractures following iliac artery stenting Wataru Higashiura, MD, Yasushi Kubota, MD,

Magdiel Trinidad-Hernandez, MD, Joseph J

Endovascular native vessel recanalization to maintain limb perfusion after infected prosthetic vascular graft excision Victor Z. Erzurum, MD, Dan Clair,

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting? Richard.

Infected aneurysm of the thoracic aorta

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Miguel Montero-Baker, MD, Gregory J

Treatment of limb-threatening ischemia with percutaneous intentional extraluminal recanalization: a preliminary evaluation Gerald S Treiman, MD, John.

The compatibility of p-branch “off-the-shelf” fenestrated endovascular graft in Asian patients with juxtarenal aortic aneurysm Jiale Ou, MBBS, MMed,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Outcomes of reinterventions after subintimal angioplasty

Chetan P. Huded, MD, Philip P. Goodney, MD, Richard J

Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions Gautam V. Shrikhande, MD,

Misaki M. Kiguchi, MD, MBA, Luke K. Marone, MD, Rabih A

Successful treatment of jellyfish sting-induced severe digital ischemia with intravenous iloprost infusion Arthur H. Lo, MBBS, Yiu Che Chan, MBBS, BSc,

Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Peter Neglén, MD, PhD, Kathryn C. Hollis, BA, Seshadri Raju, MD

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

LEA 20. Aneurysm of Persistent Sciatic Artery With Acute Lower Limb Ischemia—Hybrid Approach in Management Roshan Rodney S., MBBS, MS, DNB, K.N. Nagabhushan,

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Primary stenting of the superficial femoral and popliteal artery

Balloon angioplasty vs nitinol stent placement in the treatment of venous anastomotic stenoses of hemodialysis grafts after surgical thrombectomy John.

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Harshal Broker, MD, G. Patrick Clagett, MD Journal of Vascular Surgery

Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Supra-aortic hybrid endovascular procedures for complex thoracic aortic disease: Single center early to midterm results Yiu Che Chan, BSc MB, BS, MD,

Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries Laura A. Karch, MD, Mark A. Mattos, MD,

Karen J. Ho, MD, Christopher D. Owens, MD, MSc

Endovascular repair of an acute blunt popliteal artery injury

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Impact of Dual Antiplatelet Therapy on Superficial Femoral Artery Stent Patency in the Vascular Study Group of New England Ryan M. Svoboda, Karina A.

Reduction in deep vein reflux after concomitant subfascial endoscopic perforating vein surgery and superficial vein ablation in advanced primary chronic.

Femorofemoral bypass with femoral popliteal vein

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Successful treatment of jellyfish sting-induced severe digital ischemia with intravenous iloprost infusion Arthur H. Lo, MBBS, Yiu Che Chan, MBBS, BSc,

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Endovascular interventions for TASC II D femoropopliteal lesions

Connie Zastrow, MD, Raghu L. Motaganahalli, MD, FRCS, Jon S

Thigh claudication due to profunda femoris artery occlusion

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Surgical management of popliteal artery aneurysms: Which factors affect outcomes? Raffaele Pulli, MD, Walter Dorigo, MD, Nicola Troisi, MD, Alessandro.

Presentation transcript:

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W. Cheng, MS, FRCS, Albert C. Ting, MS, FRCS, Grace C. Cheung, MMedSc Journal of Vascular Surgery Volume 59, Issue 2, Pages 384-391 (February 2014) DOI: 10.1016/j.jvs.2013.08.037 Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 1 Example of popliteal angioplasty and stent placement. Journal of Vascular Surgery 2014 59, 384-391DOI: (10.1016/j.jvs.2013.08.037) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 2 Plain radiographs of the stents postprocedure to detect fractures. Journal of Vascular Surgery 2014 59, 384-391DOI: (10.1016/j.jvs.2013.08.037) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 3 Primary patency rate on follow-up of 83.5% in 6 months and 78.6% in 12 months A, Primary patency rate subgroup analyses as femoral/popliteal involvement. B and C, Primary patency rate subgroup analyses as claudication/threatened limb as indication for treatment. POP, Popliteal artery; SFA, superficial femoral artery. Journal of Vascular Surgery 2014 59, 384-391DOI: (10.1016/j.jvs.2013.08.037) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 4 Primary patency rate subgroup analyses as length of stent used. Journal of Vascular Surgery 2014 59, 384-391DOI: (10.1016/j.jvs.2013.08.037) Copyright © 2014 Society for Vascular Surgery Terms and Conditions